Heparin-binding protein (HBP) antibody and antigen (Recombinant protein)
Diagnostic Heparin-binding protein (HBP) antibodies (anti-Heparin-binding protein, anti-ALB) and antigens (recombinant Heparin-binding protein (HBP) protein) for Inflammation/autoimmune/inflammatory disease ALB detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Inflammation/autoimmune/inflammatory disease diagnostics products collection
>>
Product information
Size: 1mg | 10mg | 100mg
Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
---|---|---|---|---|
GMP-h-HBP-Ag01 | Recombinant human AZU1/ALB Protein | 3090 | ||
GMP-h-HBP-Ab01 | Anti-human AZU1/HBP mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-h-HBP-Ab02 | Anti-human AZU1/HBP mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-h-HBP-Ab03 | Anti-human AZU1/HBP human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-h-HBP-Ab04 | Anti-human AZU1/HBP human monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
Cat No. of Products | GMP-h-HBP-Ag01 |
Product Name | Recombinant human AZU1/ALB Protein |
Target/Biomarker | Heparin-binding protein (ALB) |
Alias of Target/Biomarker | AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC, hHBP |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Heparin-binding protein (ALB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ALB level test of Inflammation/autoimmune/inflammatory disease (inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human AZU1/ALB Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-HBP-Ab01, GMP-h-HBP-Ab02 |
Product Name | Anti-human AZU1/HBP mouse monoclonal antibody (mAb) |
Target/Biomarker | Heparin-binding protein (ALB) |
Alias of Target/Biomarker | AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC, hHBP |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Heparin-binding protein (ALB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ALB level test of Inflammation/autoimmune/inflammatory disease (inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human AZU1/HBP mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-HBP-Ab03, GMP-h-HBP-Ab04 |
Product Name | Anti-human AZU1/HBP human monoclonal antibody (mAb) |
Target/Biomarker | Heparin-binding protein (ALB) |
Alias of Target/Biomarker | AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC, hHBP |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Heparin-binding protein (ALB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ALB level test of Inflammation/autoimmune/inflammatory disease (inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human AZU1/HBP human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The incidence of sepsis increases with ageing, rise in cancer incidence and popularity of invasive medical operations.1 2 Rapid detection and optimised treatment are the keys to successful treatment of sepsis.3 To facilitate earlier recognition and more timely management of patients with sepsis or those at risk of developing the condition, the European Society of Intensive Care Medicine and Society of Critical Care Medicine published new diagnostic criteria for sepsis and septic shock.4 Nevertheless, due to time delay, low sensitivity and lack of specificity,5 the existing diagnosis indicators such as microbial culture, complete blood count, and levels of procalcitonin (PCT) and C reactive protein (CRP) are inadequate for timely clinical diagnosis of sepsis and septic shock. Heparin-binding protein (HBP) is precomposed and mainly exists in the azurophilic granules (almost 74% in content) and secretory vesicles (almost 18% in content) of neutrophils. Azurophilic granules show low tendency to be released from cells, and they are only released when neutrophils infiltrate tissues.6 The release of easily mobilised HBP from secretory vesicles has important functions during early events in inflammatory processes. HBP works by activating various cell types.7 Previous studies have shown that the plasma HBP level is significantly elevated in sepsis combined with organ dysfunction, which is the best probe for the progression of sepsis.3 8 Given the capacity of HBP to identify infection and vascular leakage in patients, it is also an interesting candidate marker to monitor patients with sepsis and septic shock.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments